How Does Doping Control Work? A Complete Breakdown from In-Competition Testing Procedures, Out-of-Competition No-Notice Testing to the Whereabouts System

Most people imagine doping control as “pulling a few athletes aside to pee in a cup after the race.” That image isn’t wrong, but it’s only the very end of the chain—and the least important part. What truly determines whether an anti-doping system works is who is tested, when, and with what methods—in other words, the design of the testing plan and the whereabouts system that supports it.

This article breaks down the “process”: from the moment an athlete is placed in a testing pool, to the doorbell ringing at 7 a.m., to the sample leaving the venue, entering the laboratory, producing a report, and triggering the results management process—what exactly happens in between.

Let’s set the premise first: this article explains the general operational logic of the system, not a procedural manual to be followed point-by-point. International standards for testing and investigations, laboratories, and sample analysis are all revised periodically, and implementation details vary by country and event. For any specific time limits, frequencies, volumes, or format requirements, always defer to the latest official documents and the rules of your governing organization. This article provides no doping advice whatsoever.

---

1. First, a fundamental question: why “testing only on race day” doesn’t work

This is the starting point for understanding the entire system.

For many performance-enhancing methods, the time when they exert their effect is separate from the time when they can be detected. Take substances that enhance strength and recovery: their value lies in allowing you to handle greater training loads and recover faster from intense sessions during the training period. By race day, the drug itself may have long been metabolized, but the training adaptations it helped you build are still there. Blood manipulation works the same way—the critical operations may occur weeks before the competition.

In other words, if a system only tests on race day, it will only catch the few who try to “get a quick boost right before the event,” while completely missing the core problem of “systematic use during training.” This is why out-of-competition testing is the mainstay of modern anti-doping, while in-competition testing is more of a basic threshold.

For out-of-competition testing to be effective, two conditions must be met: no advance notice and the ability to locate the athlete. The former rules out the possibility of “being notified in advance and having time to prepare”; the latter—this is the entire reason the whereabouts system exists. This system is so controversial precisely because it is the foundation of the entire out-of-competition testing framework; remove it and the whole structure collapses.

---

2. Who gets tested? The tiered logic of the testing pool

Not all registered athletes are treated equally. The system is designed with a tiered + risk-based approach.

Tier	General Target	Whereabouts Obligations	Testing Type
Registered Testing Pool (RTP)	Highest-priority athletes designated by International Federations or National Anti-Doping Organizations, typically world-class or core national team members	Most stringent: must regularly file detailed whereabouts, including a daily designated 60-minute time slot	High-frequency out-of-competition + in-competition
Secondary / General Testing Pool	Athletes at a certain competitive level but not top priority	Simplified: may only need to report training locations, competition schedules, and basic information	Low-to-medium frequency out-of-competition + in-competition
Event Testing Pool	All participants in a specific event (including some amateur and age-group events)	Usually no ongoing whereabouts obligations	Primarily in-competition, per event rules
General amateur riders	Those not participating in regulated events	None	Generally not subject to testing

The point of tiering is resource allocation. Testing costs money: travel for doping control officers, cold-chain transport of samples, laboratory analysis fees—every test is a real expense. Spreading a limited budget evenly across everyone means no one is effectively monitored. So the system concentrates its firepower on the group most likely to have problems and where the consequences are most severe.

This also answers a common question: “Why does it seem like so-and-so is rarely tested?” It’s usually not deliberate leniency, but rather that the athlete isn’t in the highest-priority tier, or the testing resources in that country or sport are limited to begin with. Regional disparities in testing density are one of the most real and intractable inequalities of this system.

---

3. Testing plans aren’t drawn from a hat: intelligence-driven test allocation

Early test allocation relied considerably on randomness. The current mainstream approach is the risk-assessment-based Test Distribution Plan, whose core concept is: different sports, different disciplines, and different phases of the season face different doping risk profiles, and testing resources should be allocated accordingly.

For road cycling, for example, the risk assessment generally considers factors such as:

• The physiological demands of the discipline. A sport highly dependent on aerobic capacity and recovery speed naturally has a risk profile tilted toward oxygen transport and recovery methods, so testing items and timing should match.
• The season cycle. The high-volume base phase in winter and the race-dense period in-season present different risk profiles. The period traditionally considered highest risk is “the time furthest from competition, when testing is least expected,” which is why modern testing plans deliberately invest resources in the off-season.
• The athlete’s performance trajectory. Abnormal changes in the performance curve or unusual fluctuations in physiological parameters can trigger additional testing.
• Intelligence. Information from whistleblowers, cooperation with customs and law enforcement, financial flows, and networks of individuals connected to past cases.

The last item is the biggest shift of the past two decades. Anti-doping organizations now commonly have investigative departments, not just testing departments. This means testing is no longer just “getting randomly selected,” but may be precisely targeted based on specific leads. Conversely, this brings new controversy: intelligence-driven testing means greater discretion, and how to avoid targeting and abuse is an ongoing challenge.

---

4. In-competition sample collection: a doping control begins the moment you’re notified

Suppose you’re in an event with doping control, and you’re notified for testing after crossing the finish line. What happens next generally follows the process below.

Stage	Content	Where athletes most often go wrong
1. Notification	A Doping Control Officer (DCO) or chaperone shows credentials, informs you that you’ve been selected, and asks you to sign the notification form	Signing without carefully reading the rights and obligations on the form
2. Chaperoning	From the moment of notification, you must generally remain within sight of the chaperone until sample collection is complete	Showering, changing clothes, leaving the venue, or walking away to take a phone call on your own
3. Reasonable delay	You may request a delay before reporting to the doping control station to handle necessary matters (cool-down, medal ceremony, media interviews, medical treatment, retrieving personal identification, etc.)	Doing these things on your own instead of “making a request and doing them under chaperone supervision”
4. Reporting and waiting	Arrive at the station, present identification, and wait for collection	Forgetting your ID; drinking beverages of unknown origin in the waiting area
5. Selecting the vessel	You choose from multiple sealed collection kits yourself	Failing to check that the seal is intact
6. Providing the sample	Provide a urine sample under direct visual observation by the DCO	Lack of mental preparation for the discomfort of this step
7. Splitting into A/B bottles	You split the sample into the A and B bottles and seal them yourself	Not confirming the caps are properly tightened or checking the code numbers
8. On-site measurement	The DCO measures suitability indicators (e.g., specific gravity) of the remaining sample	If it doesn’t meet requirements, you must provide again, which can lengthen the wait
9. Completing the form	Declare medications, prescriptions, and supplements used in the recent period	Omitting something—this section is extremely important later
10. Verification and signature	Verify code numbers, check for any procedural irregularities, and sign	Having concerns but not writing them in the “comments” section on the spot

A few points worth expanding on:

On “reasonable delay.” The system is not unreasonable. Medal ceremonies, media interviews, necessary cool-down exercises, and necessary medical treatment can usually be requested. The key action is “making the request” and “doing it under supervision.” The most common problem for athletes isn’t refusing the test, but “not realizing they’re already in the testing process” and casually doing what they’d normally do.

On the medication declaration section. At the moment of collection, this section looks like mere administrative process, but it is the starting point for all future explanations. If the sample returns an adverse finding and you honestly declared a prescription drug or supplement at the time, that materially helps your later explanation. Conversely, if you were using something and didn’t declare it, only to raise it after the result comes out, your credibility takes a serious hit. Filling this out honestly and completely is the cheapest insurance an athlete can buy.

On the comments section. If anything seems wrong during the collection process—the kit seal looks compromised, the procedure is interrupted, or you’re asked to wait under unreasonable conditions—write it in the comments section on the spot and sign. Raising procedural defects after the fact is almost ineffective in litigation.

On minors and athletes with disabilities. The system generally provides accommodations for these groups (e.g., the right to have a representative present). If you’re a parent or coach, understanding these rights in advance is essential.

On blood samples. Beyond urine, blood collection accounts for an increasing share of modern testing. Blood samples have their own specific procedural requirements, such as a period of seated rest before collection and attention to posture and exercise status beforehand. These requirements aren’t arbitrary—blood parameters are highly sensitive to these conditions.

---

5. Out-of-competition testing: the doorbell rings at 7 a.m.

The defining feature of out-of-competition testing is no advance notice. The DCO won’t call ahead or schedule a time; they may show up at your home, a training camp accommodation, a gym, or even an airport.

From the moment of notification, the procedure is largely the same as in-competition testing: chaperoning, reporting, selecting the kit, providing the sample, splitting, completing the form, and signing. The difference lies in the precondition: the DCO must first be able to find you.

This brings us to the whereabouts system.

Why a whereabouts system is necessary

Imagine a world without a whereabouts system. To test an athlete, a DCO would have to show up at their registered address and hope for the best. If the athlete isn’t there, the trip is wasted, and the cost is still incurred. If an athlete is intent on evading, they just need to “happen not to be home” during specific periods, and out-of-competition testing becomes a dead letter—and those periods might be exactly when monitoring is most needed.

The function of the whereabouts system is to turn “being findable” from the DCO’s luck into the athlete’s obligation.

What must be filed

Athletes in the Registered Testing Pool generally need to file information in advance for a future period, usually quarterly, through a designated online system, covering roughly:

• Nightly accommodation address (where you’ll sleep each night)
• Regular activities, locations, and times (training venues, workplace, school, etc.)
• Competition schedule
• A daily designated 60-minute time slot: athletes must specify a fixed one-hour window each day and the specific location where they’ll be during that window; during this time, the athlete must be findable at that location

Moreover, this information must be updated in real time. Last-minute schedule changes, a different place to stay, an early end to a training camp—all must be immediately reflected in the filing. Most systems offer mobile apps specifically to reduce the friction of updates.

Common misconceptions about the 60-minute slot

This is the most misunderstood element. The designated 60-minute slot does not mean you can only be tested during those 60 minutes. DCOs can show up at any time of day at any location you’ve filed (within the hours permitted by the rules). The meaning of the 60-minute slot is: if you can’t be found during that window, it’s recorded as a “missed test”; if you can’t be found at other times, it generally isn’t counted as a missed test.

In other words, the 60-minute slot is a minimum commitment of “guaranteed availability,” not a protective umbrella of “testing can only happen during this time.”

The three-strikes rule

Whereabouts violations are divided into two types under the rules:

Type	When it occurs	Plain English
Filing Failure	Failing to file by the deadline, incomplete filing, or incorrect information that makes you unfindable	“You never made clear where you were”
Missed Test	Being unfindable at the filed location during your designated 60-minute slot	“You said where you’d be, but you weren’t there”

When these two types of failures accumulate to the specified number (three in recent rules) within a certain period (calculated on a rolling 12-month basis in recent rules), they constitute a standalone anti-doping rule violation—note that this violation exists with no positive sample whatsoever. Please refer to the latest version of the International Standard for the actual time period and threshold.

The system also provides recourse: for each recorded failure, the athlete can submit an explanation and request review. If it can be shown that the cause was not attributable to the athlete (e.g., system malfunction, the DCO failing to follow procedure in attempting contact, or a sudden medical emergency), the record may be overturned.

Why this system is constantly criticized

The whereabouts system is the most intrusive part of the entire anti-doping framework on an individual’s personal life, and the criticisms carry real weight. They deserve a neutral hearing:

• Privacy. You must continuously disclose to an organization where you sleep every night and where you are during the day. This exists in almost no other profession.
• Psychological burden. The state of “someone might ring the doorbell at any moment,” sustained over time, creates real stress for some athletes. The anxiety of forgetting to update your whereabouts is itself a persistent cognitive load.
• Unequal burden. Those with caregiving responsibilities, those who travel frequently, and those with irregular routines face significantly higher compliance costs.
• Data security. If this data leaks, it implicates the physical safety of athletes and their families. Major athlete data breaches have indeed occurred in the past, making data protection a component the system must continuously strengthen.

The response from supporters is: without this system, out-of-competition testing cannot be effectively implemented; and without effective out-of-competition testing, the deterrent power of the entire anti-doping framework drops dramatically. Recent adjustments to the system have generally aimed at reducing the burden while maintaining effectiveness—simplifying filing interfaces, narrowing the pool of those required to file detailed whereabouts, and clarifying recourse procedures.

For the vast majority of amateur athletes, the whereabouts system does not apply. But understanding it helps you see the situation professional athletes face, and why “out-of-competition testing” is so critical in the institutional framework.

---

6. After the sample leaves the venue: laboratory analysis

Once the sample is sealed, packed, and its chain of custody documented, it’s sent to an accredited laboratory. Several key design features matter here.

Laboratories must be accredited. Only laboratories that pass an accreditation process may perform official sample analysis. Accreditation covers equipment, personnel qualifications, method validation, quality management, and regular proficiency testing. This ensures that the same sample should yield consistent conclusions regardless of which accredited laboratory analyzes it.

Analysis proceeds in two stages: screening and confirmation. The screening stage uses faster, higher-throughput methods to initially flag suspicious samples; flagged samples then move to the confirmation stage, where more specific and rigorous methods confirm the identity of the substance. Only after passing confirmation does an Adverse Analytical Finding (AAF) result.

The A and B bottle design. The sample is split into two bottles from the start. The A bottle is used for analysis; if the A bottle produces an adverse finding, the athlete has the right to request that the B bottle be opened for confirmatory analysis, and may (personally or through a representative) witness the opening. If the B bottle result does not support the A bottle, the case generally ends. This design is meant to provide a safeguard against laboratory error.

Samples can be stored long-term and re-analyzed. This is a major source of deterrence. Testing technology improves; substances undetectable today may have methods developed years later. The rules therefore permit re-analysis of stored samples within the statute of limitations (the current version of the rules sets a considerable period; check the latest version for the exact number of years). This means “not detectable now” does not equal “safe forever” —a fact proven in practice by retrospective re-analysis at several major events.

---

7. Biological passport: from “finding substances” to “watching the body”

Traditional testing logic is “find the prohibited substance in the sample.” But some methods—particularly blood manipulation and the use of preparations highly similar to naturally occurring substances—are difficult to catch with this logic, because what you’re looking for is nearly identical to what the body already produces.

The Athlete Biological Passport (ABP) changes the question: instead of asking “is there a foreign substance,” it asks “can this person’s physiological parameter changes be explained by normal physiological variation?”

Its operational logic is longitudinal monitoring:

1. For the same athlete, samples are collected repeatedly at different time points, measuring a defined set of biological markers.
2. A statistical model builds the athlete’s individualized normal range—the key word being “individualized,” not applying population reference values.
3. Each new measurement updates the model’s expected interval for that person.
4. When a result falls outside the individualized expectation, or the overall pattern of change looks non-physiological, the system flags an anomaly.
5. An expert panel (typically independent specialists in hematology, endocrinology, etc.) reviews the case to determine whether the pattern can be explained by normal physiology, illness, altitude training, or other factors.

The ABP typically includes a hematological module (focusing on patterns of change in oxygen-transport-related parameters) and a steroidal module (focusing on ratios between endogenous steroids). Additional modules are under ongoing development.

The value and limitations of the ABP

Aspect	Description
Primary value	Even if the substance itself can’t be caught, it may detect the “fingerprints of manipulation”; can independently constitute evidence of a violation
Secondary value	Serves as an intelligence source, triggering targeted additional testing (abnormal pattern appears → more tests)
Limitation 1	Requires sufficient longitudinal data points to have discriminatory power; effectiveness is limited with sparse data
Limitation 2	Altitude training, illness, dehydration, pregnancy, and blood donation all affect parameters and must be excluded by experts
Limitation 3	Sensitivity decreases for “low-dose, fine-tuning” manipulations
Limitation 4	High implementation cost; requires stable testing frequency and data management capacity, making full implementation difficult for organizations with limited resources

There’s an extension of understanding the ABP that’s meaningful for amateur athletes too: it demonstrates that “looking at change patterns with longitudinal data” is more powerful than “single-point checks.” The same thinking applies to training monitoring—a single day’s heart rate, body weight, or blood value means little; it’s the long-term trend for the same person that has interpretive value.

---

8. Emerging sampling methods

Dried Blood Spot (DBS) sampling has begun to be introduced into official testing in recent years. The method collects a small amount of blood onto a specialized filter paper card, which is then dried for storage and transport. Compared to traditional venous blood collection, its advantages are:

• Less invasive, faster to collect, and less burdensome for the athlete
• More flexible transport and storage conditions, no strict cold chain required, greatly reducing the difficulty of implementation in remote areas
• Lower cost, allowing more tests within the same budget

Its limitation is the small sample volume, meaning the range of analyzable parameters differs from traditional samples, so it currently serves as a complement to existing methods rather than a replacement. The long-term significance of this technology may lie in narrowing the testing density gap between different countries—which, as noted earlier, is the system’s greatest inequality.

---

9. After an adverse finding: results management

A sample testing positive doesn’t mean the case is over; it means the process is just beginning. The general flow is roughly as follows:

1. Initial review. Confirm whether a valid Therapeutic Use Exemption (TUE) exists for the substance and whether there are obvious procedural defects. If an exemption or clear procedural issue exists, the case may end here.
2. Notification of the athlete. Inform them of the adverse analytical finding, the substance involved, and their rights, including requesting B bottle analysis and access to the full laboratory documentation package.
3. Provisional Suspension. Depending on the substance category and the rules, this may be automatic or discretionary; the athlete is barred from competition before the case is finalized. This step often sparks controversy because it imposes a real disadvantage at a stage where “no violation has yet been established.”
4. Athlete’s response. The athlete may explain the source, present evidence, and claim no fault or no significant fault.
5. Hearing process. Conducted by an independent hearing body with jurisdiction.
6. Decision. Determines whether a violation occurred, the sanction period, and whether results are disqualified.
7. Appeal. May be filed with the appellate body as provided by the rules; at the international level, the Court of Arbitration for Sport (CAS) is typically the final instance.

Notably, there’s the cascading effect of “result disqualification.” In the case of an adverse finding from in-competition testing, the results of that event are typically automatically disqualified; whether results from other events in the same period are also disqualified depends on the rules and the specifics of the case. For team events, this can affect teammates and the entire team’s results—which is why anti-doping culture within a team is not merely an individual matter.

---

10. Common procedural disputes

A large portion of anti-doping litigation isn’t about “whether they used” but about “whether the process was done correctly.” Common points of dispute include:

• Whether the chain of custody was complete. Whether every handoff of the sample from collection to analysis was documented and unbroken.
• Whether the notification procedure was proper. The DCO’s identification, and the manner and timing of notification.
• Whether laboratory methods complied with standards. Whether analytical methods followed the standards, instruments were regularly calibrated, and personnel qualifications were met.
• The proportionality of provisional suspension. How to weigh the real harm to an athlete’s career from being barred before a violation is established.
• Implementation of the B bottle procedure. Whether the athlete was given adequate opportunity and time to be present.
• Timeliness of case processing. If the time from sample collection to decision drags on excessively, the uncertainty imposed on the athlete is itself a form of harm.

Understanding these points helps you read the news with more nuance: a case being “dismissed” or “not established” may mean substantive proof of innocence, or it may mean procedural defects rendered the evidence inadmissible—these two are not the same in meaning. Likewise, a case being established doesn’t necessarily imply intent—the variation in sanction length often reflects precisely this judgment.

---

11. What amateur athletes can learn from this

Even if you’ll never be placed in a Registered Testing Pool, this process offers several lessons directly useful to you.

One: If your event has doping control, spend ten minutes understanding the process beforehand. Most “procedural mishaps” stem from not knowing the rules, not from trying to evade them. Knowing “you can’t walk off on your own after notification” and “you can request to attend the medal ceremony under supervision” avoids the most common pitfalls.

Two: Develop the habit of recording your medications. The medication declaration section on the collection form can’t be accurately reconstructed from memory on the spot. If you use any prescription drugs or supplements, keep a list on your phone (name, ingredients, dosage, start and end dates, prescribing physician) and fill it in directly from that list during testing.

Three: Bring the “trend over single point” mindset into your training. The core insight of the biological passport is the power of longitudinal data. Your resting heart rate, body weight, sleep, and training load on any single day mean almost nothing, but long-term trends will honestly tell you the state of your body.

Four: Understand that “not detectable now” doesn’t mean “safe forever.” The existence of sample re-analysis means there’s no window of impunity on this front. The same logic extends to health: the cost of certain methods may only manifest years later.

Five: Consult before any medication decision. Whether it’s a cold, allergies, a chronic condition, or post-surgical care, consult a physician or pharmacist before use, and proactively inform them that you are an athlete subject to anti-doping rules. This sentence is the only piece of advice that remains unchanged across this entire series of articles, because it’s the only thing entirely within your own control.

---

Key Takeaways

1. Out-of-competition testing is the mainstay, because the timing of effect and the timing of detection are often separate for many methods; in-competition testing is more of a basic threshold.
2. The testing pool uses a tiered + risk-based design, concentrating resources on high-priority tiers; regional disparities in testing density are the system’s most real inequality.
3. Modern testing plans are intelligence-driven rather than purely random; anti-doping organizations commonly have investigative departments, and the share of non-analytical cases has risen significantly.
4. Across the ten stages of in-competition collection, the most common mistake isn’t refusing the test, but “not realizing you’re already in the process”—showering, leaving the venue, or walking off to take a call after notification.
5. The medication declaration and comments sections are the athlete’s cheapest insurance: fill them honestly and completely, and write any concerns into the comments on the spot and sign.
6. The whereabouts system turns “being findable” into the athlete’s obligation; the 60-minute slot is a “minimum commitment of guaranteed availability,” not a “testing can only happen during this time” umbrella.
7. Filing failures and missed tests accumulating to the threshold within a given period constitute a standalone violation, with no positive sample required.
8. Samples are split into A and B bottles, and the athlete has the right to request B bottle confirmation; samples can be stored long-term and re-analyzed as technology advances.
9. The biological passport changes the question from “is there a substance” to “can the physiological changes be explained by normal physiology,” relying on individualized longitudinal data and expert review; it has value and clear limitations.
10. An adverse analytical finding is only the beginning of the process; what follows includes notification, provisional suspension, response, hearing, decision, and appeal; a case not being established may mean substantive innocence or procedural defects, and the two are different in meaning.

One final reminder: this article explains the general operational logic of the system and cannot replace official regulatory texts, nor does it constitute any medical or medication advice. For specific procedures, time limits, thresholds, and determination criteria, please refer to the latest official announcements from WADA, the UCI, and your national anti-doping organization; for any medication decision, consult a physician or pharmacist first, and proactively disclose your athlete status.

Related Reading

• What Is Anti-Doping Control Actually About? From the Three Criteria of the Prohibited List to What Amateur Riders Should Know
• How to Design a Race-Day Nutrition Plan: A Practical Framework from the Week Before to Every Hour After the Start
• Prohibited Substances and Sport: The Science of Anti-Doping and How to Protect Yourself with Clean Supplements
• Practicing Nutrition in Training: Why Race Nutrition Should Be Rehearsed on Long Training Days